Navigation Links
Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting
Date:5/15/2008

a experienced a 20 percent tumor reduction. Lastly, a patient with NK/T cell lymphoma had a 75 percent reduction in tumor measurements. Adverse events included two Grade 3 dose- limiting toxicities (upper respiratory infection (URI) and elevated liver enzymes) and five cases of Grade 3 thrombocytopenia (low-platelet count) without any sign of bleeding.

Reductions in platelet counts were analyzed in the three ongoing Phase I trials as a biomarker of Bcl-2 family protein inhibition. Subjects received doses ranging from 10 mg to 315 mg. The study data demonstrate that ABT-263 induces a transient decrease in circulating platelets via inhibition of Bcl- XL, without decreasing platelet production, confirming on-target activity. At 315 mg, researchers observed a 69 percent reduction in mean platelets from baseline values. Typically, platelet nadir occurred on days three to five with recovery during continued dosing. Tumor regression was observed in six patients, with three patients showing more than 50 percent tumor shrinkage. Adverse events included three dose-limiting toxicities, one Grade 3 URI at 160 mg, one Grade 3 alanine aminotransferase (ALT) elevation at 315 mg and one fatal respiratory failure at 10 mg. Updated information will be presented at the ASCO Annual Meeting.

ABT-869

Twenty-four patients from a completed Phase I trial (ABT-869), which studied three dose levels of ABT-869, were evaluated to compare two different measures of angiogenesis using functional imaging -- the distributed parameter (DP) model and the transfer constant (Ktrans) model. DP is a dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) model that enables derivation of blood flow and capillary permeability-surface area product (PS). Tests indicated that time over threshold could be an important predictor of efficacy, and results demonstrated that an appropriate value for the plasma concentration threshold could be 0.08 ug/mL, with time above threshold value of
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Abbott to Present at Citi Investment Research Global Health Care Conference
2. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
4. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
5. Innovative Diagnostic Instrument Introduced by Abbott for Low- to Mid-Volume Laboratory Market Segment
6. Abbott FreeStyle Freedom(R) Lite Blood Glucose Monitoring System Now Available With No Coding for People With Diabetes
7. Abbott Hosts Conference Call for First-Quarter Earnings
8. Takeda, Abbott Announce Plans to Conclude TAP Joint Venture
9. FDA Approves Abbotts FreeStyle Navigator(R) Continuous Glucose Monitoring System
10. Abbott Receives CE Mark for Smaller-Size XIENCE(TM) V Drug Eluting Stent
11. Abbott, Genentech and WEHI Collaborate to Research and Develop New Anti-Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2015)... On May 16, the team at ... a 5k mud obstacle run that raised funds for multiple ... worldwide, and the reason we participated was to support people ... of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised ... event was not only attended by eXtreme Bodyshaping staff, but ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 A live auction ... equipment from hospitals, surgery centers and other medical facilities around ... sold including endoscopy, lab, radiology, surgery, anesthesia, exam and much ... May 27 and Thursday, May 28 starting at 9:00am CDT ... at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ProFlare ... simple as dragging and dropping footage into the FCPX timeline ... , Including over 80 stunning flares, ProFlare 5K Prism ... the ultimate bundle for adding prismatic refractions to any video. ... movie files designed for Final Cut Pro X, but are ...
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... 2015 The American College of Traditional ... June. They will hold a webinar on the updates ... class on Classical Chinese Medicine. , Webinar – First ... Given, the Dean of Clinical Education, will lead this ... Professional Doctorate program. ACTCM is currently developing this degree ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2
... with muscle-thickening disorder may also identify children at risk ... 10 gene mutations responsible for cardiac hypertrophy (thickening of ... many cases of this rare but life-threatening condition in ... showed up in children who had no family history ...
... Muneo Takashi has been,named to head the Chicago ... As the new Chief Executive Director, Takashi follows ... assignment in Chicago., As Chief Executive Director, ... activities designed to facilitate business development,between Japan and ...
... Tripled dose was ineffective and toxic, so strategy should ... News) -- High-intensity chemotherapy does not improve the survival ... a new Swiss study concludes. , Testing on 140 ... differences in survival rate or tumor size between groups ...
... Researchers at Boston College have developed the first laboratory ... Using their novel cell line, the team discovered one of ... attack. , The development of a new animal model ... that displays the full spectrum of systemic metastatic cancer ...
... remains,underdiagnosed and undertreated even though this neurologic ... options have increased in the,last decade., ... treat this neurologic,sleep disorder, The Journal of ... supplement "Stay awake! Understanding, diagnosing, and,successfully managing ...
... 9 United Heartland is pleased to,announce that ... of,Community Providers has earned a record dividend of ... performance of the group,s 48 members, which,achieved an ... http://www.newscom.com/cgi-bin/prnh/20080409/CLW076LOGO ), The Iowa Association of ...
Cached Medicine News:Health News:Gene Mutations for Rare Heart Disease Also Found in Kids 2Health News:Muneo Takashi Named Chief Executive Director of Japan's Midwest Trade Office 2Health News:High-Dose Chemo Fails Against Small Cell Lung Cancers 2Health News:Boston College biologists build a better mouse model for cancer research 2Health News:United Heartland Group Program Earns Record Dividend 2
(Date:5/22/2015)... , May 22, 2015 The Assistance Fund ... This program provides financial assistance for copay to individuals ... to announce the addition of the Melanoma Copay Assistance ... Mark McGreevy , executive director. "With each additional program ... of a world where no one is denied access ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... tissue protection, repair and regeneration, today announced that ... scheduled to present a corporate overview at two upcoming ... at the SeeThruEquity 4 th Annual Microcap Conference ... York City at 11:00 am EDT.  A ...
(Date:5/22/2015)...  The Mesothelioma Victims Center is incredibly passionate ... the best possible compensation, and they are also extremely ... cancer caused by exposure to asbestos or their ... treatment options such as a recent possible medical breakthrough. ... Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... Chindex International, Inc. (NASDAQ: CHDX ), ... China through the operations of United Family Healthcare, a network ... announced financial results for the third quarter and first nine ... Third Quarter 2011 Financial Highlights ...
...  Inova Labs, a privately held medical ... Chronic Obstructive Pulmonary Disease (COPD) market, announced today that ... financing for up to $17.5M from an investment syndicate ... Calif. The company plans to use the capital to ...
Cached Medicine Technology:Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 2Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 3Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 4Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 5Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 6Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 7Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 8Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 9Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 10Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 11Inova Labs Closes on $17.5M Series B Financing 2
Bailey lachrymal cannula, 7 mm exposed tip, 8 mm reinforced....
Lachrymal cannula, straight....
Shahinian lacrimal cannula, bullet shaped tip, 0.3 mm side opening, straight....
Solo-care is a multi-purpose solution for cleaning, rinsing, disinfection and storing soft contact lenses....
Medicine Products: